The United States Food and Drug Administration (FDA) currently stands at a precarious crossroads. Following the sudden...
Treatment Innovations
In an era where healthcare systems are grappling with rising labor costs, persistent drug shortages, and the...
In a significant advancement for inpatient diabetes care, Glooko has secured US Food and Drug Administration (FDA)...
By Jonathan Gardner | BioPharma Dive Published May 15, 2026 In a development that has sent shockwaves...
After years of grappling with declining R&D returns and the "post-pandemic hangover," the global biopharmaceutical sector has...
In a significant stride for urological healthcare, Butterfly Medical has announced the successful completion of its pivotal...
Wisconsin-based medical technology firm Rivermark Medical has announced the successful closure of a $20 million Series D...
In a significant advancement for clinical endocrinology, Revvity has secured US Food and Drug Administration (FDA) clearance...
By Ben Fidler | May 14, 2026 The race to redefine treatment for Duchenne muscular dystrophy (DMD)...
The global biotechnology landscape is witnessing a seismic shift as German mRNA pioneer BioNTech, once the face...
